7-2432855-G-C
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_018641.5(CHST12):āc.216G>Cā(p.Lys72Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000123 in 1,461,490 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (ā ). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. K72R) has been classified as Uncertain significance.
Frequency
Consequence
NM_018641.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
CHST12 | NM_018641.5 | c.216G>C | p.Lys72Asn | missense_variant | 2/2 | ENST00000618655.2 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
CHST12 | ENST00000618655.2 | c.216G>C | p.Lys72Asn | missense_variant | 2/2 | 1 | NM_018641.5 | P1 | |
CHST12 | ENST00000258711.7 | c.216G>C | p.Lys72Asn | missense_variant | 2/2 | 1 | P1 | ||
CHST12 | ENST00000432336.1 | c.216G>C | p.Lys72Asn | missense_variant | 2/2 | 2 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD3 exomes AF: 0.0000799 AC: 20AN: 250216Hom.: 0 AF XY: 0.0000811 AC XY: 11AN XY: 135562
GnomAD4 exome AF: 0.0000123 AC: 18AN: 1461490Hom.: 0 Cov.: 32 AF XY: 0.0000110 AC XY: 8AN XY: 727074
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 05, 2022 | The c.216G>C (p.K72N) alteration is located in exon 2 (coding exon 1) of the CHST12 gene. This alteration results from a G to C substitution at nucleotide position 216, causing the lysine (K) at amino acid position 72 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at